Root Financial Partners
PTCT icon

Root Financial Partners’s PTC Therapeutics PTCT Stock Holding History

Root Financial Partners’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.3K Buy
+175
New +$12.7K ﹤0.01% 1856
2026
Q2 		– Sell
-157
Closed -$10.7K – 2481
2026
Q1 		$10.7K Buy
157
+23
+17% +$1.63K ﹤0.01% 1660
2025
Q4 		$10.2K Buy
134
+36
+37% +$2.62K ﹤0.01% 1484
2025
Q3 		$6.01K Buy
+98
New +$5.1K ﹤0.01% 1648

Other funds holding PTCT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Root Financial Partners's PTCT Position: Q3 2026 in Review

Root Financial Partners opened a new position in PTC Therapeutics (PTCT) in Q3 2026: 175 shares worth $11.3K. The stake represents ﹤0.01% of the portfolio and ranks #1856 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in PTCT as recently as Q1 2026.

Root Financial Partners first reported a position in PTCT in Q3 2025 and has held it in 4 quarters since. 183 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.

  • Root Financial Partners held 175 shares of PTC Therapeutics worth $11.3K as of Q3 2026.
  • PTC Therapeutics was a new Root Financial Partners position in Q3 2026.
  • PTC Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #1856 holding.
  • Root Financial Partners first reported a position in PTC Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 183 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.